Lipid accumulation product had high potential in predicting the risk of gout/hyperuricemia in new research, offering a potentially modifiable risk factor for preventing gout.1
“Traditional metrics for evaluating obesity, such as Body Mass Index (BMI) and Waist Circumference (WC), have been widely utilized; however, they exhibit significant limitations in accurately reflecting the complex nature of adiposity and its associated health risks. In this context, the novel Lipid Accumulation Product (LAP), which integrates WC and fasting triglycerides (TG), emerges as a promising alternative. This innovative metric not only enhances the precision of obesity assessment but also serves as a potential indicator for cardiovascular diseases and metabolic syndrome, thereby highlighting the substantial implications of this research…